DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Ornstein MC, Pal SK, Wood LS. et al.
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Lancet Oncol 2019;
20: 1386-1394
DOI: 10.1016/s1470-2045(19)30513-3.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.